Ibn Sina (c. 980-1037 CE), known in the Latin West as Avicenna, was a Persian philosopher and physician who became one of the most influential thinkers of the Islamic Golden Age. Serving in the courts of various rulers in Iran and Central Asia, he wrote extensively on medicine, philosophy, logic and the natural sciences; his medical encyclopedia, The Canon of Medicine, systematized the medical knowledge of his era and was used as a standard medical textbook in European universities for centuries after its Latin translation. His philosophical writings, which sought to reconcile Aristotelian and Neoplatonist thought with Islamic theology, also had a lasting influence on medieval European Scholastic philosophy, and he is regarded as one of the greatest physicians and thinkers in history.
Facts
Birth YearWikipedia gives this as a circa (approximate) year, not exactly attested. RolePhilosopher and physician of the Muslim world during the Islamic Golden Age 1 Role
Role (category) Connections
In Era
Source Wikipedia: Ibn Sina (Avicenna)
In the Other Atlases
Same As
Also in Philosophy Atlas: the same subject.
Originated In
Also in Geography Atlas: where this subject originated.
Sources
1. Wikipedia: Ibn Sina (Avicenna)
WikipediaWikipedia lead paragraph, opening parenthetical (birth/death dates)
c. 980-22 June 1037
Wikipedia lead paragraph, first sentence, occupation clause
was a preeminent philosopher and physician of the Muslim world
Wikipedia lead paragraph, first sentence, Western-name clause
commonly known in the West as Avicenna
Ibn Sina: Gender
Serving in the courts of various rulers in Iran and Central Asia, he wrote extensively on medicine, philosophy, logic and the natural sciences; his medical encyclopedia, The Canon of Medicine, systematized the medical knowledge of his era and was used as a standard medical textbook in European universities for centuries after its Latin translation.
In Era: The Post-Classical and Medieval Period, lead paragraph, lifespan
Infobox: born c. 980; died 1037-6-22
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.